MTOR and astrocytoma (excluding glioblastoma): These observations are consistent with the increased frequency of PTEN protein loss in high-grade gliomas, particularly astrocytomas, encountered by us, which would lead to the increased activation of PI3K/AkT/mTor pathway with consequent activation of its downstream effectors as reported [10,23].